The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia). The study will randomly assign 42 participants with acrophobia to one of two conditions: a) the experimental condition (consisting of 3 sessions of virtual reality exposure) or b) a control condition. Both groups will receive short information session about general principles of exposure therapy before the start of the study. After the end of the study, the waitlist group will be invited to attend the short version (one or two-sessions) of the VRET. Both groups will receive a final follow-up questionnaires 2 months after the last session.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Visual Height Intolerance Severity Scale (vHISS)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Score)
Visual Height Intolerance Severity Scale (vHISS)
Timeframe: 2-months Post-Treatment (Controlling for Immediate Post-Treatment Score)
Severity Measure for Specific Phobia-Adult (SMSP-A)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Score)
Severity Measure for Specific Phobia-Adult (SMSP-A)
Timeframe: 2-months Post-Treatment (Controlling for Immediate Post-Treatment Score)
The IAPT phobia scale-avoidance
Timeframe: 2-Weeks In-Treatment (Controlling for Baseline Score)
The IAPT phobia scale-avoidance
Timeframe: Immediately Post-Treatment (Controlling for Baseline Score)
The IAPT phobia scale-avoidance
Timeframe: 2-months Post-Treatment (Controlling for Immediate Post-Treatment Score)